Akermin

About:

Akermin focuses on developing commercial applications in wireless sensors for military uses.

Top Investors: Chrysalix Venture Capital, St. Louis Arch Angels, Emerson Ventures, Prolog Ventures, OnPoint Technologies

Description:

Akermin is based in St. Louis, Missouri, and was formed in 2004 to commercialize breakthrough stabilized enzyme technology invented at Saint Louis University. In 2008, Akermin demonstrated its prototype of a fully functioning biofuel cell operating on methanol fuel and using stabilized laccase to replace the metal catalyst in conventional cathodes. Commercial applications in wireless sensors and military uses are their primary focus. Development for the use of stabilized enzymes in the food processing, biofuels, chemical, and pharmaceutical industries is under way.

Total Funding Amount:

$25.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)akermin.com

Founders:

Shelley Minteer

Number of Employees:

11-50

Last Funding Date:

2013-10-21

IPO Status:

Private

Industries: